Literature DB >> 30772360

Defining a "High Volume" Radical Cystectomy Hospital: Where Do We Draw the Line?

Sohrab Arora1, Jacob Keeley2, Amit Patel3, Sriram V Eleswarapu4, Chandler Bronkema5, Shaheen Alanee3, Mani Menon3.   

Abstract

BACKGROUND: Centralization of radical cystectomy (RC) to "high volume" centers can lead to decreased morbidity but also limits access to care. In the context of centralization, there is a need to systematically define the hospital volume cutoffs for this procedure.
OBJECTIVE: To systematically examine the effect of hospital volume on inpatient complications of RC for bladder cancer and to define a threshold to minimize RC morbidity. DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective analysis of data for 6790 adults undergoing RC for nonmetastatic bladder cancer during 2008-2011 from the National Inpatient Sample (weighted population estimate of 33 249 RCs in the USA during this period). INTERVENTION: RC. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Overall and major complications were defined according to International Classification of Diseases (9th revision) diagnosis and procedure codes. To define the relationship between hospital volume and morbidity, logistic regression analyses within a generalized estimating equation framework with restricted cubic splines were used. RESULTS AND LIMITATIONS: The inpatient complication rate was 4769/6790 (70.2%), of which 1572/6790 (23.2%) were major complications. Restricted cubic spline analysis revealed a significant inverse nonlinear association between hospital volume and complications. The odds of complications decreased with increasing volume, with a plateau at 50-55 cases/yr for any complications (p=0.024) and 45-50 cases/yr for major complications (p=0.007).
CONCLUSIONS: The relationship between hospital volume and RC morbidity is nonlinear, with a plateau for the complication rate at 50-55 cases/yr. Restricting RC to centers with such high thresholds will restrict access to care. There is a need to identify and publish best practices from high-volume centers in quality improvement initiatives to improve morbidity at low-volume centers. PATIENT
SUMMARY: There is a nonlinear relationship between the annual number of radical cystectomy procedures performed at a hospital and the inpatient complication rate. Complications decrease with increasing hospital volume and reach a plateau at 50-55 cases per year, beyond which the incremental benefit of increasing volume is minimal.
Copyright © 2019 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bladder neoplasms; Hospital volume; National Inpatient Sample; Radical cystectomy; Robotic radical cystectomy

Mesh:

Year:  2019        PMID: 30772360     DOI: 10.1016/j.euf.2019.02.001

Source DB:  PubMed          Journal:  Eur Urol Focus        ISSN: 2405-4569


  4 in total

1.  Experience of surgeon, hospital, and comprehensive cancer team critical to the outcomes of radical cystectomy and urinary diversion.

Authors:  Ram Anil Pathak; Ashok Kumar Hemal
Journal:  Transl Androl Urol       Date:  2019-07

2.  Charlson comorbidity score is associated with readmission to the index operative hospital after radical cystectomy and correlates with 90-day mortality risk.

Authors:  Coleman McFerrin; Syed Johar Raza; Allison May; Facundo Davaro; Sameer Siddiqui; Zachary Hamilton
Journal:  Int Urol Nephrol       Date:  2019-07-25       Impact factor: 2.370

3.  Improving outcomes of radical cystectomy: A call for passive over active regionalization.

Authors:  Girish S Kulkarni
Journal:  Can Urol Assoc J       Date:  2020-04-01       Impact factor: 1.862

4.  Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer: A Randomized Clinical Trial.

Authors:  James W F Catto; Pramit Khetrapal; Federico Ricciardi; Gareth Ambler; Norman R Williams; Tarek Al-Hammouri; Muhammad Shamim Khan; Ramesh Thurairaja; Rajesh Nair; Andrew Feber; Simon Dixon; Senthil Nathan; Tim Briggs; Ashwin Sridhar; Imran Ahmad; Jaimin Bhatt; Philip Charlesworth; Christopher Blick; Marcus G Cumberbatch; Syed A Hussain; Sanjeev Kotwal; Anthony Koupparis; John McGrath; Aidan P Noon; Edward Rowe; Nikhil Vasdev; Vishwanath Hanchanale; Daryl Hagan; Chris Brew-Graves; John D Kelly
Journal:  JAMA       Date:  2022-06-07       Impact factor: 157.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.